D. Welsh (Glasgow, United Kingdom), R. Schermuly (Giessen, Germany)
LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension
C. Happé, M. A. de Raaf, I. Schalij, A. Vonk-Noordegraaf, N. Westerhof, F. S. de Man, H. J. Bogaard (Amsterdam, Netherlands)
|   |
Granulysin in pulmonary veno-occlusive disease
F. Perros, S. Cohen-Kaminsky, N. Gambaryan, B. Girerd, N. Raymond, I. Klingelschmitt, A. Huertas, O. Mercier, E. Fadel, G. Simonneau, M. Humbert, P. Dorfmüller, D. Montani (Le Kremlin-Bicêtre, Le Plessis-Robinson, France)
| |
Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
M. P. Winter, A. Alimohammadi, A. Panzenboeck, M. Sibilia, F. Nagel, D. Santer, B. Podesser, S. Alias, M. Frey, I. Lang (Vienna, Austria)
| |
Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats
O. Sellier-Kessler, E. Chevalier (Allschwil, Switzerland)
| |
TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats
S. Guo, T. Wang, G. He, D. Xu, F. Wen (Chengdu, China)
| |
Heme oxygenase-1 and inflammation in experimental right ventricular failure on prolonged overcirculation-induced pulmonary hypertension
A. Belhaj, L. Dewachter, F. Kerbaul, S. Brimioulle, C. Dewachter, R. Naeije, B. Rondelet (Bruxelles, Yvoir, Belgium; Marseille, France)
| |
Contributions of TRPV4 to altered pulmonary vasoreactivity in mice with pulmonary hypertension
Y. Xia, Z. Fu, O. Paudel, J. Sham (Baltimore, United States Of America)
| |
Dilatation reserve of pulmonary arteries at stages of COPD experimental model
N. Kuzubova, E. Lebedeva, A. Fedin, T. Preobrazhenskaya (St. Petersburg, Russian Federation)
| |
Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH)
M. Leberl, R. Chen, Z. Moumen, M. Zamora, L. Taraseviciene-Stewart (Aurora, St. Louis, United States Of America)
| |
Imatinib lowers the pulmonary vascular tone in human and guinea pig lung tissue
N. A. Maihöfer, M. Schlepütz, J. W. Spillner, T. Schröder, R. Autschbach, S. Westphal, A. Perez-Bouza, T. Braunschweig, G. Schaelte, R. Rossaint, S. Uhlig, C. Martin, A. D. Rieg (Aachen, Bonn, Germany)
| |
A soluble guanylate cyclase stimulator, BAY 41-8543, preserves pulmonary artery endothelial function in experimental pulmonary embolism
J. Watts, M. Gellar, M. B. Fulkerson, H. Quach, J. Kline (Charlotte, Indianapolis, United States Of America)
| |
Ample safety margins exist for clinical development of inhaled AIR001 (Sodium nitrite) in pulmonary arterial hypertension (PAH)
J. Tepper, H. Masamune, P. Rix, E. Parsley (San Carlos, San Diego, United States Of America)
| |
Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH)
L. Taraseviciene-Stewart, M. Leberl, Z. Moumen, R. Kadam, U. Kompella, M. Zamora, A. Kratzer (Aurora, United States Of America)
| |
Blunted effects of rho-kinase inhibitor, fasudil, on pulmonary arterial pressure in Yak, a high altitude-adapted animal
T. Ishizaki, A. Sakai, B. Kojonazarov, B. Zamirbek, S. Mizuno, S. Ameshima, A. Aldashev (Fukui, Matsumoto, Kanazawa, Japan; Bishkek, Kyrgyzstan)
| |
Siah2 in pulmonary hypertension and right ventricular hypertrophy
D. Haag, D. M. Peters, B. Kojonazarov, S. Kraut, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, A. Möller, M. L. Schmitz, N. Weissmann (Giessen, Germany; Herston, Brisbane, Australia)
| |
Nitric oxide and beta2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice
S. Shinomiya, T. Shibamoto, S. Mizuno, K. Osanai, H. Toga (Kanazawa, Japan)
| |
Correction of endothelial dysfunction by inhibitors of phosphodiesterase-5 in combination with L-arginine
T. Pokrovskaya, M. Pokrovsky, E. Dudina, E. Konovalova, V. Kochkarov, I. Kolesnik, M. Korokin, O. Gudyrev, A. Arustamova, R. Bontsevich, A. Chetverikova, I. Korobtsova (Belgorod, Kursk, Russian Federation)
| |
Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of leptin and endothelin-1
S. Gomart, C. Damoiseaux, P. Jespers, N. Labranche, S. Pochet, R. Naeije, K. Mc Entee, L. Dewachter (Brussels, Belgium)
| |